Compare AFCG & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AFCG | BTMD |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.8M | 71.0M |
| IPO Year | 2020 | 2021 |
| Metric | AFCG | BTMD |
|---|---|---|
| Price | $3.33 | $2.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.50 | $2.83 |
| AVG Volume (30 Days) | 173.8K | ★ 206.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | ★ 0.49 | 0.06 |
| Revenue | $24,563,601.00 | ★ $192,219,000.00 |
| Revenue This Year | $1,334.03 | $2.03 |
| Revenue Next Year | $17.33 | $6.58 |
| P/E Ratio | ★ $6.98 | $41.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.06 | $1.27 |
| 52 Week High | $5.10 | $4.75 |
| Indicator | AFCG | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 56.02 |
| Support Level | $3.20 | $1.97 |
| Resistance Level | $3.37 | $2.37 |
| Average True Range (ATR) | 0.15 | 0.15 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 3.70 | 66.67 |
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.